Apollo Global Management told allocators in August that direct lending—the strategy that absorbed $427 billion in commitments since 2019—now represents a shrinking wedge of deployable private credit capital. The firm and peers including Ares Management and Blue Owl Capital are launching €1 billion secondaries-focused vehicles and moving LP conversations toward portfolio credit, structured products, and non-sponsored lending. The reframe arrives as direct lending funds report average deployment periods stretching past 31 months, double the 2021 pace.
The mechanics are specific. Apollo's newest fund targets private credit secondaries and stressed situations rather than primary syndicated loans to sponsor-backed companies. Blue Owl filed for a $2.8 billion CLO in July. Ares confirmed in earnings that fewer than half of new commitments in Q2 went to traditional direct lending mandates. Allocators who spent 2020-2023 hearing that private credit *was* direct lending now hear that direct lending is 15-18% of the opportunity set, depending on which deck they're shown. The fastest capital raise in alternative assets history is being re-classified mid-flight.
This matters because the original thesis assumed operating company demand would grow faster than capital supply. It did not. Sponsored LBO volume fell 22% year-over-year through July. Meanwhile, private credit AUM crossed $1.6 trillion, creating a structural oversupply in the vanilla direct lending market. Managers face a choice: return capital, cut fees, or redefine the mandate. They are choosing the third. Secondaries funds allow managers to buy seasoned loan books at discounts, immediately deploy capital, and market illiquidity as alpha rather than friction. Broader portfolio strategies let them chase yield in asset-backed lending, real estate credit, and infrastructure without the sponsored-deal dependency that has turned into a bottleneck.
For allocators, this creates two risks. First, the liquidity profile changes. Direct lending funds had observable cash flow from amortizing loans; secondaries and structured products do not. Second, the skill set required is different. Buying a performing €340 million loan book from a distressed manager is not the same underwriting motion as originating a €50 million unitranche for a software buyout. The firms pivoting fastest may not have the talent depth in the new strategies they are marketing. Family offices and fund-of-funds that allocated $60-120 million to direct lending on the assumption of predictable, floating-rate income now hold exposure to portfolios that increasingly include mezzanine tranches, real estate credit, and secondary loan purchases trading at 82-88 cents on the euro.
Operators should watch three developments. First, whether the €1 billion secondaries funds achieve target returns or become forced sellers in 18-24 months when denominator effects hit. Second, whether sponsors push back on pricing as credit funds diversify away from their deals, potentially tightening LBO financing again. Third, whether the SEC or European regulators start scrutinizing the re-characterization of fund mandates without explicit LP consent, especially for funds still in their commitment period. The first secondaries fund marks will print in Q4 2025.
The firms that called direct lending the future of corporate finance now call it a product line. The allocators who believed them are holding the term sheets.